SEC Comment Letter for EXICURE, INC. (XCUR) (CIK 0001698530) (XCUR) — Jul 18, 2022
EXICURE, INC. (XCUR) (CIK 0001698530)
Date: July 18, 2022 · CIK: 0001698530 · Accession: 0000000000-22-007529
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-266093
Letter
United States securities and exchange commission logo July 18, 2022 Matthias Schroff, Ph.D. Chief Executive Officer Exicure, Inc. 2430 N. Halsted St. Chicago, IL 60614 Re:Exicure, Inc. Registration Statement on Form S-3 Filed July 11, 2022 File No. 333-266093 Dear Dr. Schroff: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dillon Hagius at 202-551-7967 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Marc Recht
Show Raw Text
United States securities and exchange commission logo
July 18, 2022
Matthias Schroff, Ph.D.
Chief Executive Officer
Exicure, Inc.
2430 N. Halsted St.
Chicago, IL 60614
Re:Exicure, Inc.
Registration Statement on Form S-3
Filed July 11, 2022
File No. 333-266093
Dear Dr. Schroff:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dillon Hagius at 202-551-7967 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Marc Recht